3CPM Company, Inc.

3CPM Company, Inc. is a US-based medical device manufacturer specializing in electrogastrography (EGG) diagnostic systems for gastrointestinal motility disorders. The company's proprietary technology combines miniaturized hardware with AI-driven software for non-invasive characterization of gastroparesis, functional dyspepsia, and related GI conditions. The EGG platform features a simple 45-minute test protocol with automated signal acquisition and evidence-based diagnostic interpretation. 3CPM's patented technology enables disease subtyping to optimize personalized treatment selection and identify potentially curable subsets of patients (25% of gastroparesis and dyspepsia cases). The system provides objective diagnosis of dyspepsia, gastroparesis, reflux, motility disorders, pyloric dysfunction, and associated symptoms (nausea, vomiting, bloating, abdominal distension, and pain). Built on 30 years of AI development, device engineering, and medical simulation integration, the platform is FDA-approved as the only approved device for non-invasive electrogastrographic diagnosis. 3CPM markets to gastroenterology practices, hospitals, and ambulatory surgical centers, emphasizing improved patient outcomes, increased satisfaction, and positive cash flow for healthcare facilities.